Large-scale testing (Phase 3)Study completedNCT03242018
What this trial is testing
Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control
Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 4
Lexicon Pharmaceuticals 277